Search Results 2401-2410 of 20235 for Receptor

  1. A Study Evaluating MM-310 in Patients With Solid Tumors - Mayo Clinic

    MM-310 is a liposomal formulation of a docetaxel prodrug that targets the EphA2 receptor on cancer cells. Docetaxel is an approved chemotherapeutic drug ...

  2. Innovative Mayo Clinic test may improve mesothelioma detection rate in blood

    Mayo Clinic researchers have developed an innovative testing strategy for mesothelioma that could potentially increase the detection rate of cancer DNA in ...

  3. A Dose Escalation Study of HFB301001 in Adult Patients with Advanced Solid Tumors - Mayo Clinic

    - Prior exposure to agents targeting the OX40 receptor; - Active autoimmune disease requiring systemic treatment in the previous 2 years; - Systemic steroid ...

  4. A Study to Evaluate DS-1062a Combined with Pembrolizumab in Advanced or Metastatic Non-Small Cell Lung Cancer Without Actionable Genomic Alterations - Mayo Clinic

    ... receptor (eg, CTLA-4, OX 40, CD137). * Received a live vaccine within 30 days prior to the first dose of study treatment. * Active, known, or suspected ...

  5. Physical Medicine and Rehabilitation News - Medical Professionals - Mayo Clinic

    Impact of PAR1 on inflammation and recovery after spinal cord injury. Mayo Clinic researchers offer insight into the role of the thrombin receptor, also known ...

  6. A Study of SAR442085 in Relapsed or Refractory Multiple Myeloma - Mayo Clinic

    ... receptor on effector cells in patients with relapsed and/or refractory (RR) MM. Read More on PubMed. Additional contact information. Cancer-related trials ...

  7. Left ventricular hypertrophy - Diagnosis and treatment - Mayo Clinic

    Angiotensin II receptor blockers. Also called ARBs, these medicines have benefits similar to ACE inhibitors but don't cause a persistent cough. Beta ...

  8. Neurosciences Clinical Trials - Medical Professionals

    ... receptor (ER and PR) all negative], HER2 positive whatever the ER/PR status,, and HER2 negative/ER positive), (5) advanced, unresectable colorectal cancer ...

  9. A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (Meteoroid) - Mayo Clinic

    ... receptor (NMDAR) encephalitis - Any concomitant disease other than MOGAD that may require treatment with ISTs or OCS or intravenous (IV) corticosteroids at ...

  10. Modified VR-CAP and Acalabrutinib as First Line Therapy for the Treatment of Transplant-Eligible Patients With Mantle Cell Lymphoma - Mayo Clinic

    * Note: H2-receptor agonists are not exclusionary * History of allergic reactions attributed to acalabrutinib, cytarabine, bortezomib, boron, or any of the ...